{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:57:14Z","timestamp":1781539034366,"version":"3.54.5"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Hospital-based ophthalmology faces increasing demand for long-term monitoring of neovascular age-related macular degeneration (nAMD). Safe redistribution of routine monitoring to community clinicians is relevant to integrated community (primary)\u2013secondary care models.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine whether community optometrist\u2013led monitoring of nAMD is noninferior to hospital-based monitoring for detecting disease activity requiring treatment.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This multicenter, noninferiority randomized clinical trial was conducted from October 8, 2019, to January 31, 2024, at secondary centers (17 hospitals) and primary centers (60 community optometry practices) with 12-month follow-up. Statisticians were masked to patient grouping. Adults 55 years or older with quiescent AMD in at least 1 eye (and quiescent or nonneovascular disease in the other) were recruited at participating hospitals. Data analysis was performed from October 2024 to March 2025.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomized 1:1 to monitoring sessions once every 2 months in hospitals (control) or community practices (intervention). Trained and accredited optometrists performed optical coherence tomography imaging, clinical examination, patient management, and online reporting at each visit.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome (participant level) was a binary indicator of whether a false-negative clinical management decision occurred at any visit within 12 months (missed quiescent nAMD reactivation or new fellow-eye nAMD, adjudicated by a central reading-center reference standard). The noninferiority margin was a 10\u2013percentage point absolute risk difference. Secondary outcomes were false-positive clinical management decisions, attendance adherence, visual acuity change, harms, loss to follow-up, suspicious classifications, and confirmation visit outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 704 randomized participants, 635 (90.2%) completed at least 1 follow-up visit, including 287 at community practices (mean [SD] age, 80.6 [8.1] years; 236 [67.4%] female) and 348 at hospitals (mean [SD] age, 80.1 [8.5] years; 203 [57.3%] female). False-negative clinical management decisions occurred in 11 of 287 community participants (3.8%) vs 27 of 348 hospital participants (7.8%) (risk difference, \u22123.9 percentage points; 95% CI, \u22127.4 to \u22120.3 percentage points;\n P<\/jats:italic>\n \u2009=\u2009.04; adjusted odds ratio, 0.51; 95% CI, 0.24-1.07;\n P<\/jats:italic>\n \u2009=\u2009.08), meeting noninferiority. False-positive clinical management decisions occurred in 24 of 287 community participants (8.4%) vs 12 of 348 hospital participants (3.5%) (risk difference, 4.9 percentage points; 95% CI, 0.9-9.0 percentage points). Findings were consistent across per-protocol, cluster-adjusted, and relative risk sensitivity analyses. No adverse event\u2013related withdrawals occurred.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, community optometrist\u2013led monitoring of quiescent nAMD was noninferior to hospital monitoring for detecting disease activity requiring treatment. These results provide evidence for its use in integrated clinical care models.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT03893474<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.17984","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:48Z","timestamp":1781537448000},"page":"e2617984","source":"Crossref","is-referenced-by-count":0,"title":["Community Optometrist\u2013Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration"],"prefix":"10.1001","volume":"9","author":[{"given":"Anitta","family":"Sharma","sequence":"first","affiliation":[{"name":"Moorfields Ophthalmic Reading Centre and Artificial Intelligence Lab, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Optometry, Moorfields Eye Hospital Foundation Trust, London, UK"},{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljazy","family":"Jaber","sequence":"additional","affiliation":[{"name":"Moorfields Ophthalmic Reading Centre and Artificial Intelligence Lab, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishwanath","family":"Pal","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Medical Retina Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Lawrenson","sequence":"additional","affiliation":[{"name":"School of Health and Medical Sciences, City St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harper","sequence":"additional","affiliation":[{"name":"Manchester Royal Eye Hospital, Manchester University NHS Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Tufail","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Medical Retina Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annastazia E.","family":"Learoyd","sequence":"additional","affiliation":[{"name":"School of Population Health and Environmental Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Robinson","sequence":"additional","affiliation":[{"name":"School of Population Health and Environmental Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Douiri","sequence":"additional","affiliation":[{"name":"School of Population Health and Environmental Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Burman","sequence":"additional","affiliation":[{"name":"School of Population Health and Environmental Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Kernohan","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Vougioukalou","sequence":"additional","affiliation":[{"name":"Centre for Adult Social Care Research (CARE) and Centre for Trials Research (CTR), Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Read","sequence":"additional","affiliation":[{"name":"NIHR Health Determinants Research Collaboration Torfaen, Torfaen County Borough Council, Torfaen, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Csontos","sequence":"additional","affiliation":[{"name":"Wales Centre For Evidence Based Care and School of Healthcare Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aled","family":"Jones","sequence":"additional","affiliation":[{"name":"School Nursing and Midwifery, University of Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Manchester Royal Eye Hospital, Manchester University NHS Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"McKibbin","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Foundation Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Peacock","sequence":"additional","affiliation":[{"name":"School of Population Health and Environmental Sciences, King\u2019s College London, London, UK"},{"name":"Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth College, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gale","sequence":"additional","affiliation":[{"name":"Hull York Medical School, University of York, York, UK"},{"name":"York and Scarborough Hospitals, NHS Foundation Trust, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen J.","family":"Patel","sequence":"additional","affiliation":[{"name":"Moorfields Ophthalmic Reading Centre and Artificial Intelligence Lab, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Medical Retina Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[{"name":"Moorfields Ophthalmic Reading Centre and Artificial Intelligence Lab, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"},{"name":"Medical Retina Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Hamilton","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Medical Retina Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Vale","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK"},{"name":"Global Health Economics Centre and Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[{"name":"Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Balaskas","sequence":"additional","affiliation":[{"name":"Moorfields Ophthalmic Reading Centre and Artificial Intelligence Lab, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"2","key":"zoi260508r1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/pmrj.13027","article-title":"Effectiveness of care models for chronic disease management: a scoping review of systematic reviews.","volume":"16","author":"Kroenke","year":"2024","journal-title":"PM R"},{"issue":"1","key":"zoi260508r2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5334\/ijic.5508","article-title":"Integrating primary and secondary care to enhance chronic disease management: a scoping review.","volume":"21","author":"Murtagh","year":"2021","journal-title":"Int J Integr Care"},{"issue":"1","key":"zoi260508r3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/13814788.2021.1954616","article-title":"Task shifting in primary care to tackle healthcare worker shortages: an umbrella review.","volume":"27","author":"Leong","year":"2021","journal-title":"Eur J Gen Pract"},{"issue":"1","key":"zoi260508r4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11764-021-01128-1","article-title":"Effectiveness and implementation of models of cancer survivorship care: an overview of systematic reviews.","volume":"17","author":"Chan","year":"2023","journal-title":"J Cancer Surviv"},{"key":"zoi260508r5","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2023.15","article-title":"Heart failure nurses within the primary care setting.","volume":"10","author":"Hill","year":"2024","journal-title":"Card Fail Rev"},{"issue":"2","key":"zoi260508r6","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"7","key":"zoi260508r7","doi-asserted-by":"publisher","first-page":"e1175","DOI":"10.1016\/S2214-109X(25)00143-3","article-title":"Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"13","year":"2025","journal-title":"Lancet Glob Health"},{"key":"zoi260508r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.01.073","article-title":"Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trial.","author":"Jaffe","year":"2013","journal-title":"Ophthalmology"},{"key":"zoi260508r9","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-024-06605-8","article-title":"Incidence and risk factors of fellow-eyes wet conversion in unilateral neovascular age-related macular degeneration over 15-year follow-up.","author":"Sadeghi","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"zoi260508r10","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2017.0022","article-title":"Morphologic criteria of lesion activity in neovascular age-related macular degeneration: a consensus article.","author":"Miotto","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"zoi260508r11","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/bjophthalmol-2015-308077","article-title":"UK Neovascular Age-Related Macular Degeneration Database: report 6: time to retreatment after a pause in therapy: outcomes from 92?976 intravitreal ranibizumab injections.","volume":"100","author":"Madhusudhana","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"zoi260508r12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/ceo.14444","article-title":"Reactivation of stable neovascular age-related macular degeneration following treat-and-extend regimen discontinuation.","volume":"53","author":"Artiaga","year":"2025","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"zoi260508r14","first-page":"2437","article-title":"OCT-based automated analysis for detection of exudative activity in AMD.","volume":"120","author":"Sisternes","year":"2013","journal-title":"Ophthalmology"},{"key":"zoi260508r16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1283496","author":"Jahn","year":"2011","journal-title":"Gesundheitswesen"},{"issue":"1","key":"zoi260508r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000671","article-title":"Danish teleophthalmology platform reduces optometry referrals into the national eye care system.","volume":"6","author":"Muttuvelu","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"issue":"5","key":"zoi260508r18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/opo.12312","article-title":"Effectiveness of UK optometric enhanced eye care services: a realist review of the literature.","volume":"36","author":"Baker","year":"2016","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"zoi260508r19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41433-023-02820-5","article-title":"Providing capacity in glaucoma care using trained and accredited optometrists: a qualitative evaluation.","volume":"38","author":"Gunn","year":"2024","journal-title":"Eye (Lond)"},{"issue":"14","key":"zoi260508r20","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41433-023-02444-9","article-title":"Implementation and scalability of shared care models for chronic eye disease: a realist assessment informed by health system stakeholders in Finland, the United Kingdom, and Australia.","volume":"37","author":"Ford","year":"2023","journal-title":"Eye (Lond)"},{"issue":"2-3","key":"zoi260508r21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000484099","article-title":"Development of age-related macular degeneration (AMD) in the fellow eye of patients with AMD treated by treat-and-extend intravitreal therapy with aflibercept.","volume":"239","author":"Mimura","year":"2018","journal-title":"Ophthalmologica"},{"issue":"10","key":"zoi260508r22","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.ophtha.2013.03.017","article-title":"Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.","volume":"120","author":"Maguire","year":"2013","journal-title":"Ophthalmology"},{"issue":"7","key":"zoi260508r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010685","article-title":"Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial.","volume":"6","author":"Reeves","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"zoi260508r24","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/opo.12836","article-title":"Evaluation of training, patient and practitioner perspectives on community-based monitoring of patients with stable age-related macular degeneration compared to hospital-based care: the FENETRE study report no. 1.","volume":"41","author":"Read","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"zoi260508r25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-101379","article-title":"Comparing community-based monitoring to hospital-based care of patients with quiescent age-related macular degeneration: a qualitative study of patient and practitioner perspectives on acceptability and access.","volume":"16","author":"Vougioukalou","year":"2026","journal-title":"BMJ Open"},{"issue":"7","key":"zoi260508r26","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1097\/IAE.0000000000000513","article-title":"Relationship between visual prognosis and delay of intravitreal injection of ranibizumab when treating age-related macular degeneration.","volume":"35","author":"Takahashi","year":"2015","journal-title":"Retina"},{"issue":"3","key":"zoi260508r27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.oret.2017.07.009","article-title":"Recurrence rate of choroidal neovascularization in neovascular age-related macular degeneration managed with a treat-extend-stop protocol.","volume":"2","author":"Adrean","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"zoi260508r28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bjophthalmol-2015-307168","article-title":"Management of choroidal naevomelanocytic lesions: feasibility and safety of a virtual clinic model.","volume":"100","author":"Balaskas","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"zoi260508r29","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/bjophthalmol-2021-318816","article-title":"Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study.","volume":"106","author":"Maredza","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"zoi260508r30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055845","article-title":"Teleophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease (HERMES): a Cluster Randomised Superiority Trial with a linked Diagnostic Accuracy Study-HERMES study report 1-study protocol.","volume":"12","author":"Han","year":"2022","journal-title":"BMJ Open"},{"issue":"9","key":"zoi260508r31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/bjophthalmol-2016-309729","article-title":"Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report.","volume":"101","author":"Joachim","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"zoi260508r13","unstructured":"Healthwatch. A strain on sight: waiting for NHS specialist eye care. March 20, 2025. Accessed January 1, 2026. https:\/\/www.healthwatch.co.uk\/report\/2025-03-20\/strain-sight-waiting-nhs-specialist-eye-care"},{"key":"zoi260508r15","unstructured":"Secondary Care Open Data and Publications, NHS England. NHS England lead analyst: Karl Eichler hospital outpatient activity: 2023-2024. Accessed April 28, 2026. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/hospital-outpatient-activity\/2023-24"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850248\/sharma_2026_oi_260508_1780688423.58603.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:52Z","timestamp":1781537452000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850248"}},"subtitle":["The FENETRE Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.17984","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}